NCT Number: NCT02162745
Nasal Irrigation in Infants With Bronchiolitis.
Bronchiolitis is a leading cause of acute illness and hospitalization in the first year of life. Most children with bronchiolitis have mild disease and are managed at home with support from primary care providers, while children with more severe symptoms require supportive therapy with oxygen and fluid administration.
Neonates may be obligate nasal breathers until they are at least 2 months old and nasal obstruction may play a relevant role in respiratory resistances throughout the first months of life, whereas nasal passages may exhibit as much as 50% of the total airway resistance. Some guidelines recommend to clear the nostrils of secretions to improve airway patency but no controlled trial on the efficacy of nasal irrigation in infants with bronchiolitis was carried out.
The aim of this randomized controlled trial is to compare normal saline and hypertonic solution for nasal irrigation versus simple supportive care in infants admitted to Emergency Department with bronchiolitis and mild desaturation.
Looking for future studies?
Notify MeKey information
Conditions
Age range
1 day–365 day
Sex eligibility
All sexes
Study type
Interventional
Phase
Phase 3
Primary location
Pediatria, Azienda Ospedaliera Santa Maria Degli Angeli, Pordenone, Friuli Venezia Giulia, Italy
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- infants <1 year
- diagnosis of bronchiolitis with respiratory distress, rhinitis, cough
- oxygen saturation between 88 and 94%
Exclusion criteria
- previous treatments (nasal irrigation or suctioning, oxygen, nebulized drugs, nebulized hypertonic solution, antipyretics up to 6 hours before the study entry, oral steroids at any time before study entry)
- chronic illness
Treatment and study plan
Hypertonic solution (NaCl 3%)
DrugPrimary outcomes
-
Oxygen saturation (%)
Time frame: up to 50 minutes after allocation
Measurement of arterial oxygen saturation (SpO2) of hemoglobin with digital pulse oximeter
Secondary outcomes
-
Respiratory effort (WARME score)
Time frame: 5, 15, 20, 50 minutes after allocation
Evaluation of the respiratory effort using the validated WARME score (evaluation of: 1) respiratory rate; 2) prolonged expiration; 2) wheezing; 3) air exchange; 4) muscle use).
Sponsors and collaborators
Lead sponsor
IRCCS Burlo Garofolo
Other
Registry information
Official study title
Randomized Controlled Trial to Evaluate the Efficacy of Nasal Irrigation in Infants With Bronchiolitis
Important dates
- Study start
- 2012
- Primary completion
- 2014
- Study completion
- 2014
- First posted
- Jun 13, 2014
- Registry last updated
- Jun 13, 2014
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Evaluation of the Impact of EHR-Alerts on Clinical Decision Support Pathway Use in Bronchiolitis, and the Impact of Pathway Use on the Prescription of High Flow Nasal Cannula and Other Elements of High Value Care.
NCT06932341
Bronchial Diseases, Bronchiolitis
St. Petersburg, Florida, United States
View Trial DetailsSafe, Effective and Cost-Effective Oxygen Saturation Targets for Children and Adolescents With Respiratory Distress: a Randomized Controlled Trial
NCT06016244
Bronchial Diseases, Bronchial Hyperreactivity
Haarlem, North Holland, Netherlands
View Trial DetailsComparison Between 2l vs 3l in HFNC During the Initial Management of Severe Bronchiolitis in Infants
NCT02824744
Bronchial Diseases, Bronchiolitis
Montpellier, France
View Trial DetailsPeak Tidal Inspiratory Flow in Infants With Moderate to Severe Acute Viral Bronchiolitis
NCT03298217
Bronchial Diseases, Bronchiolitis
Montpellier, France
View Trial Details